Emerging Role of Ultrasound Imaging in the Diagnosis and Management of Skin Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: closed (31 October 2024) | Viewed by 1940

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Shanghai 200072, China
2. Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment, Shanghai 200072, China
Interests: ultrasound diagnosis; AI; telemedicine

Special Issue Information

Dear Colleagues,

In recent years, ultrasound imaging technology has been widely used and has played an increasingly important role in diagnosing and treating skin diseases, providing a large amount of key visual information in order to meet the challenges of complex skin diseases. Skin ultrasound imaging is a new technology category that is clinically widely endorsed. In this context, the large-scale application of ultrasound in skin diseases has gradually gained attention. In this regard, we would like to set up a new Special Issue on applying ultrasound imaging technology in skin diseases and focus on publishing some of the latest, high-quality, and excellent clinical research.

Dr. Lehang Guo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1891 KiB  
Article
Novel Strategy in the Detection of Adverse Cutaneous Drug Reactions: A Case Series Study
by Erika-Gyöngyi Bán, Patrick Lechsner, Eszter-Anna Dho-Nagy, Maria-Antonia Balan, István Major-Szakács, Attila Brassai, Zsuzsánna Simon-Szabó and Corina Ureche
Diagnostics 2024, 14(6), 575; https://doi.org/10.3390/diagnostics14060575 - 7 Mar 2024
Viewed by 1517
Abstract
With multimorbidity on the rise, adverse cutaneous drug reactions are becoming a daily challenge in clinical practice. The objective evaluation of the skin lesion is crucial but hardly realized due to missing technology and guidelines. In this study, the novel Dermus SkinScanner-U, an [...] Read more.
With multimorbidity on the rise, adverse cutaneous drug reactions are becoming a daily challenge in clinical practice. The objective evaluation of the skin lesion is crucial but hardly realized due to missing technology and guidelines. In this study, the novel Dermus SkinScanner-U, an optically guided high-frequency ultrasound imaging device, was evaluated regarding its comparability with the Dermatology Life Quality Index (DLQI) and the pharmacological analysis of the patients’ drug therapy. A total of 40 adult patients were evaluated, all with chronic medication use and skin lesions that led to non-compliance toward the pharmacotherapy. With the ongoing aim of further improving the methodology, the first results, with two detailed patient cases, are presented here. It was concluded that in the cases evaluated, there was a significant correlation between the characteristics of the lesions observed on the optical and ultrasound image, the DLQI score, and the pharmacological analysis. The next steps include increasing the scale of the study to ultimately develop a quality-assured methodology for the correct diagnosis of skin-related adverse drug reactions and to prepare a database with the most frequently observed events. Full article
Show Figures

Figure 1

Back to TopTop